Abstract
Background: Atherosclerotic disease is a leading cause of morbidity and mortality in adults and is generally thought of as only affecting adults. However, the pathologic changes in vessels leading to atherosclerosis, and an increased risk of cardiovascular disease, have been shown to begin in early adolescence.
Objectives: There is a growing body of literature suggesting that earlier treatment, through lifestyle changes and pharmacotherapy, can help reduce this risk. A growing number of children are presenting with elevated cholesterol because of the increased prevalence of obesity and diabetes mellitus. Methods: In addition, an increasing number of children are living with previously fatal diseases that increase the risk of atherosclerosis, either because of the disease process or as adverse effect of the treatment, such as human immunodeficiency virus, Kawasaki disease, and cardiac transplantation.
Result and Conclusion: In addition, specific disorders of cholesterol metabolism, such as Familial Hypercholesterolemia (FH) may be encountered in a pediatric practice.
Keywords: Atherosclerotic, cholesterol, Hypercholesterolemia, pharmacotherapy, atherosclerosis, disease.
Current Pediatric Reviews
Title:Treatment Strategies for Hypercholesterolemia
Volume: 13 Issue: 4
Author(s): Jacob Hartz and Sarah Clauss*
Affiliation:
- Children's National Medical Center, 111 Michigan Ave. NW, Washington, D.C. 20010,United States
Keywords: Atherosclerotic, cholesterol, Hypercholesterolemia, pharmacotherapy, atherosclerosis, disease.
Abstract: Background: Atherosclerotic disease is a leading cause of morbidity and mortality in adults and is generally thought of as only affecting adults. However, the pathologic changes in vessels leading to atherosclerosis, and an increased risk of cardiovascular disease, have been shown to begin in early adolescence.
Objectives: There is a growing body of literature suggesting that earlier treatment, through lifestyle changes and pharmacotherapy, can help reduce this risk. A growing number of children are presenting with elevated cholesterol because of the increased prevalence of obesity and diabetes mellitus. Methods: In addition, an increasing number of children are living with previously fatal diseases that increase the risk of atherosclerosis, either because of the disease process or as adverse effect of the treatment, such as human immunodeficiency virus, Kawasaki disease, and cardiac transplantation.
Result and Conclusion: In addition, specific disorders of cholesterol metabolism, such as Familial Hypercholesterolemia (FH) may be encountered in a pediatric practice.
Export Options
About this article
Cite this article as:
Hartz Jacob and Clauss Sarah*, Treatment Strategies for Hypercholesterolemia, Current Pediatric Reviews 2017; 13 (4) . https://dx.doi.org/10.2174/1573396314666180111143900
DOI https://dx.doi.org/10.2174/1573396314666180111143900 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Portal Vein Embolization: A Preoperative Approach to Improve the Safety of Major Hepatic Resection
Current Medical Imaging Pathogenesis and Treatment of Type 2 Diabetic Nephropathy: Lessons from the Spontaneous KK/Ta Mouse Model
Current Diabetes Reviews NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation
Current Immunology Reviews (Discontinued) Gastrointestinal Hemorrhage is Associated with Mortality after Acute Ischemic Stroke
Current Neurovascular Research Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease
Current Pharmaceutical Design Cardioprotective Effects of Sour Cherry Seed Extract (SCSE) on the Hypercholesterolemic Rabbit Heart
Current Pharmaceutical Design Strategies for Skeletal Muscle Targeting in Drug Discovery
Current Pharmaceutical Design Early Cerebral Infarction Following Aneurysmal Subarachnoid Hemorrhage: Frequency, Risk Factors, Patterns, and Prognosis
Current Neurovascular Research Potential Pathogenic Inflammatory Mechanisms of Endothelial Dysfunction Induced by Type 2 Diabetes Mellitus
Current Pharmaceutical Design New Immunosuppressants: Immunosuppression and Immunomodulation
Medicinal Chemistry Reviews - Online (Discontinued) Towards Standardized Stem Cell Therapy in Type 2 Diabetes Mellitus: A Systematic Review
Current Stem Cell Research & Therapy Direct Renin Inhibition: Promising Treatment in Renoprotection?
Recent Patents on Cardiovascular Drug Discovery Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Genetic Association Studies in Diabetic Nephropathy
Current Diabetes Reviews Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions
Current Diabetes Reviews Mutations of Nuclear and Mitochondrial Genomes as Potential Targets for the Treatment of Metabolic Syndrome
Current Pharmaceutical Design Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy A Review of Pharmacokinetic Parameters of Metabolites and Prodrugs
Drug Metabolism Letters